Skip to main content
Equibles

NSRX · Nasus Pharma Ltd · Analyst Estimates

Track NSRX — free

Use NSRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NSRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.40 +0.05 (+1.64%) At close · Sep 11
Rebalance outlook locked
Market Cap
$39.88M
Shares
11.71M

Analyst Estimates

Compare analyst forecasts for Nasus Pharma Ltd across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 2029039 CUSIP M7071P109 13F (30d) 6 filings 6 filers Visit website Investor relations